| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/12.2.119 |
| P698 | PubMed publication ID | 6413485 |
| P2093 | author name string | M V Hayes | |
| D C Orr | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| Pseudomonas aeruginosa | Q31856 | ||
| Staphylococcus aureus | Q188121 | ||
| ceftazidime | Q808845 | ||
| P304 | page(s) | 119-126 | |
| P577 | publication date | 1983-08-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus | |
| P478 | volume | 12 |
| Q39000262 | A Burkholderia cenocepacia MurJ (MviN) homolog is essential for cell wall peptidoglycan synthesis and bacterial viability |
| Q34057449 | A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms |
| Q34187311 | Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. |
| Q47218700 | Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms. |
| Q43111763 | Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa |
| Q35345951 | Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei |
| Q37015333 | Bacterial gene loss as a mechanism for gain of antimicrobial resistance. |
| Q34624359 | Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae |
| Q53714289 | Carbapenem Resistance: A Review. |
| Q34325573 | Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination |
| Q34402134 | Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections. |
| Q34193382 | Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. |
| Q36905255 | Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone |
| Q28821409 | DciA is an ancestral replicative helicase operator essential for bacterial replication initiation |
| Q43215544 | Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa |
| Q28298996 | Doripenem: a new carbapenem antibiotic |
| Q31073879 | Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data |
| Q92994541 | Endophthalmitis Management: Stain-Culture, Empirical Treatment, and Beyond |
| Q40376113 | Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria |
| Q35641081 | Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy |
| Q37342706 | Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients |
| Q39674604 | Hydroxyapatite/polyurethane scaffold incorporated with drug‐loaded ethyl cellulose microspheres for bone regeneration |
| Q91592671 | Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry bla NDM-1 |
| Q39818182 | In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity |
| Q39848909 | Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa |
| Q41561999 | Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. |
| Q54613484 | Pharmacodynamic effects of meropenem on gram-negative bacteria. |
| Q40283545 | Properties of the penicillin-binding proteins of four species of the genus Bacteroides. |
| Q60044061 | Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening |
| Q28551809 | Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models |
| Q92670392 | Semimechanistic Pharmacodynamic Modeling of Aztreonam-Avibactam Combination to Understand Its Antimicrobial Activity Against Multidrug-Resistant Gram-Negative Bacteria |
| Q36075788 | Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia. |
| Q68213793 | The cephalosporins |
| Q36247396 | Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response |
| Q57240408 | Translational Modeling of Antibacterial Agents |
Search more.